Planned study of NAS 911F in combination with oseltamivir (TamiFlu) in patients with influenza

Trial Profile

Planned study of NAS 911F in combination with oseltamivir (TamiFlu) in patients with influenza

Planning
Phase of Trial: Phase I

Latest Information Update: 24 Sep 2014

At a glance

  • Drugs NAS-911 (Primary) ; Oseltamivir
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors New Amsterdam Sciences
  • Most Recent Events

    • 24 Sep 2014 New trial record
    • 06 Aug 2014 A co-therapeutic study of NAS 911F with TamiFlu is planned, according to a New Amsterdam Sciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top